FDA accepts Arcutis sNDA for Zoryve cream in infants as young as 3 months

July 8, 2026 8:00 AM

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found